News A selection of press releases and news articles about Satellos. Featured Press Release Press Release 11.14.2023 SATELLOS Discloses Drug Target and Provides Development Update on Duchenne Muscular Dystrophy Program See All Press Releases Featured News In the News 03.21.2024 Developing a Small Molecule for Duchenne Muscular Dystrophy with Frank Gleeson | VibeCast Episode 48 Press Release 03.04.2024 Satellos Presents Positive Preclinical Efficacy Data for SAT-3247 at the 2024 MDA Clinical & Scientific Conference Press Release 02.21.2024 Satellos Recognized as a Top 50 TSX Venture Exchange Company In the News 02.20.2024 MD News Today: SAT-3247 Improves Muscle Function in FSHD Mouse Model Press Release 02.14.2024 Satellos to Commence Trading on the Toronto Stock Exchange Press Release 02.13.2024 Satellos Announces Promising Preliminary Data in Facioscapulohumeral Muscular Dystrophy In the News 01.24.2024 Satellos CEO Frank Gleeson Speaks with pharmaphorum at JPM24 In the News 01.15.2024 Life Sciences Ontario Announces Recipients of 2024 LSO Awards In the News 10.10.2023 Drug Target Review: Advancing Muscle Repair Discover About Duchenne Science MyoReGenX™ Investors Careers News
